# Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis

> **NCT01282398** · PHASE4 · UNKNOWN · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 80 (estimated)

## Conditions studied

- Portal Hypertension.
- Liver Cirrhosis

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01282398
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2012-04
- **Final completion:** 2015-04
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282398, "Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01282398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*